VATS lobectomy under Heliox inhalation: A randomized phase 2 trial

VATS lobectomy under Heliox inhalation: A randomized phase 2 trial - VATS lobectomy under Heliox inhalation

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025510

Enrollment

100

Registered

2017-01-04

Start date

2017-01-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer, inflammatory lung disease, metastatic lung tumor

Interventions

Heliox inhalation Conventional anaesthetic methods

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo VATS lobectomy

Exclusion criteria

Exclusion criteria: Patients with the impossible lung collapse

Design outcomes

Primary

Measure	Time frame
Improvement of visual field during surgery	—

Secondary

Measure	Time frame
safety, op. time, hospital stay	—

Countries

Japan

Contacts

Public ContactTatsuya Yoshimasu

Wakayama Medical University Department of Thoracic and Cardiovascular Surgery

yositatu@wakayama-med.ac.jp81-73-441-0615

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026